News | kaléo

Press

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues, Providing Patients Access to AUVI-Q® (epinephrine injection, USP) Through Walgreens Locations Nationwide September 6, 2018
AUVI-Q® (epinephrine injection, USP) Available in Canada Starting September 7 August 29, 2018
Kaléo Confirms U.S. Availability of AUVI-Q® (epinephrine injection, USP) Auto-injector for Back-to-School Season August 14, 2018
With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms) April 26, 2018
NASCAR Driver Elliott Sadler Teams Up with kaléo about AUVI-Q® (Epinephrine Injection, USP) to Raise Awareness of Life-Threatening Allergies April 18, 2018
EVZIO® (naloxone HCl injection, USP) Auto-Injector Now Available to Patients in Select States Without a Prescription Through Kaléo’s New Virtual Standing Order Pilot Program and to Government Agencies at a Direct Purchase Price April 5, 2018
Cabell-Huntington Health Department and the City of Huntington Fire Department Officials Named Co-Recipients of the 2017 kaléo Cares Award February 21, 2018
More than 5000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors January 11, 2018
U.S. FDA Approves Kaléo’s AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children November 20, 2017
Kaléo Along with National Advocacy Organizations Launch the “No Appetite for Bullying” Initiative October 24, 2017